July 28th, 2025: Plaintiffs Seek Mass Tort Designation for Ozempic Vision Loss Cases in New Jersey Litigation surrounding Ozempic and Wegovy is expanding beyond gastrointestinal side effects, with over 30 plaintiffs now alleging the drugs caused vision loss linked to nonarteritic anterior ischemic optic neuropathy (NAION)a condition that may result in permanent blindness
However, realistic expectations remain essential for long-term satisfaction
Across a full 12-week cycle, factoring the lighter maintenance dosing, expect to use two to three vials
We now know that for many adults with obesity, biology is the primary barrier
3hyperreflexia, e.g., coiling flexor spasm and clonus in response to light touch or stretch
Results The pilot phase (n=3,012) informed several key adjustments in the survey design